Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Biaxin

Biaxin
In stock
250mg · 500mg
from A$145.46
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$174.56A$145.46
A$5.20 per tablet

In brief

  • In our pharmacy, you can buy biaxin without a prescription, with delivery in 9–21 days throughout Australia. Discreet and anonymous packaging.
  • Biaxin (clarithromycin) is used to treat respiratory tract infections (pneumonia, bronchitis, pharyngitis), sinusitis, skin infections, Helicobacter pylori as part of triple therapy and certain mycobacterial infections; it is a macrolide antibiotic that binds the bacterial 50S ribosomal subunit and inhibits protein synthesis.
  • Usual dosage: adults 250–500 mg every 12 hours for 7–14 days (immediate‑release) or 500 mg once daily for extended‑release formulations; children typically 7.5 mg/kg every 12 hours (maximum 500 mg per dose); doses adjusted in significant renal impairment.
  • Form of administration: oral tablets (immediate‑release 250 mg and 500 mg), extended‑release tablets (500 mg) and granules for oral suspension (125 mg/5 mL, 250 mg/5 mL); IV formulations exist in some markets.
  • Onset time: symptomatic improvement is often noticed within 48–72 hours; peak plasma concentration occurs at around 2–3 hours for immediate‑release and ~4–5 hours for extended‑release formulations.
  • Duration of action: immediate‑release dosing generally provides about 12 hours of effect (twice‑daily dosing); extended‑release provides a 24‑hour effect; terminal half‑life is roughly 3–7 hours with an active metabolite that persists longer.
  • Alcohol warning: avoid or limit alcohol while taking biaxin as alcohol may worsen gastrointestinal side effects and increase liver strain; avoid alcohol if you have significant liver disease.
  • The most common side effec is nausea.
  • Would you like to try biaxin without a prescription?

Basic Biaxin Information

  • INN (International Nonproprietary Name): Clarithromycin
  • Brand Names Available In Australia: Not specified
  • ATC Code: J01FA09
  • Forms & Dosages: Immediate‑release tablets 250 mg and 500 mg; extended‑release 500 mg tablets; granules for oral suspension 125 mg/5 mL and 250 mg/5 mL.
  • Manufacturers In Australia: Not specified
  • Registration Status In Australia: Not specified
  • OTC / Rx Classification: Prescription (Rx Only) in nearly all countries.

Critical Warnings, Restrictions And Patient Protection (Australia)

Allergy checks are a first priority before supplying clarithromycin.

Confirm there is no history of macrolide allergy, including reactions to erythromycin or azithromycin.

Do not supply if there is a history of clarithromycin‑related cholestatic jaundice or hepatic dysfunction.

State that clarithromycin is prescription only and advise customers to confirm current TGA/PBS status for their brand.

High‑risk monitoring is required for renal impairment, especially CrCl <30 mL/min where dose adjustment is advised.

Severe hepatic disease, known QT‑prolonging conditions and concurrent CYP3A4 interactions are red flags.

Use this checklist of red flags to withhold supply and refer to emergency care:

  • Allergy or prior clarithromycin‑related liver injury
  • Severe jaundice, unexplained fatigue or dark urine
  • Marked bradycardia, syncope or palpitations
  • CrCl <30 mL/min without prescriber adjustment

Recommend a pharmacist‑led medication review for patients on multiple medicines.

Provide a written action plan for severe adverse effects such as jaundice, severe diarrhoea, arrhythmia signs or anaphylaxis.

Immediate Safety Priorities

Check allergy status to macrolides before supply.

Flag any history of clarithromycin‑related cholestatic jaundice or hepatic dysfunction as contraindication.

In severe illness, recommend blood‑test monitoring of liver enzymes and renal function as advised by the prescriber.

High‑Risk Groups

  • Pregnancy and breastfeeding — discuss risk versus benefit with prescriber.
  • Elderly patients with known cardiac or renal disease.
  • Patients with severe hepatic impairment.
  • People with myasthenia gravis.
  • Immunocompromised patients, including those on complex antimycobacterial regimens.

Interaction With Activities (Driving And Workplace Safety)

Clarithromycin can cause dizziness, visual disturbance or transient hearing changes.

Advise patients not to drive or operate heavy machinery if they experience these symptoms.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: Only if you feel well.

Do not drive if you experience dizziness, drowsiness or visual/hearing changes.

Australian road law requires fitness to drive and immediate medical advice is recommended if symptoms occur.

Usage Basics — INN, Brands And Legal Classification (Australian Context)

INN, Common Brands And Formulations

The International Nonproprietary Name (INN) for biaxin is clarithromycin.

Global brands include Biaxin/Biaxin XL, Klacid and Mavid, although Australian brand listings should be checked.

Common pharmaceutical forms are immediate‑release tablets (250 mg, 500 mg), extended‑release 500 mg tablets and granules for oral suspension (125 mg/5 mL, 250 mg/5 mL).

The ATC code J01FA09 classifies clarithromycin as a macrolide antibiotic.

Check the ARTG for specific brand listings before supply to confirm local registration.

Legal Classification (TGA Approval, PBS Listing And Prescription Rules)

Clarithromycin is prescription‑only in most jurisdictions and generally in Australia.

PBS listings vary by specific brand, dosage and indication so always verify current subsidy status for the brand to be dispensed.

Steps to verify: check TGA ARTG entry for the product and consult the PBS Schedule for any authority or criteria notes.

Suggested table for author drafts: brand/formulation versus PBS status and ARTG number (to be populated at time of publishing).

Dosing Guide (Standard Regimens And Adjustments)

Standard Adult And Paediatric Dosing

Typical adult dosing for respiratory and skin infections is 250–500 mg every 12 hours using immediate‑release tablets for 7–14 days.

Acute maxillary sinusitis commonly uses 500 mg every 12 hours for 14 days.

For Helicobacter pylori triple therapy the usual clarithromycin dose is 500 mg every 12 hours with amoxicillin and a proton‑pump inhibitor for 7–14 days.

Paediatric dosing is weight‑based at 7.5 mg/kg every 12 hours with a maximum of 500 mg per dose, using the oral suspension formulation.

MAC therapy and other specialist regimens follow infectious‑disease protocols and require specialist input.

Indication Adult Dose Paediatric Dose
Community‑acquired pneumonia, bronchitis, skin infections 250–500 mg every 12 hours for 7–14 days 7.5 mg/kg every 12 hours (max 500 mg/dose)
Acute maxillary sinusitis 500 mg every 12 hours for 14 days Weight‑based; max as above
H. pylori (triple therapy) 500 mg every 12 hours + amoxicillin + PPI for 7–14 days Not routine in children

Adjustments For Comorbidities

If estimated creatinine clearance is less than 30 mL/min, halve the normal dose or double the dosing interval.

Avoid clarithromycin in severe hepatic impairment where possible and monitor liver function tests if used.

In the elderly, review for drug interactions and adjust therapy as required by comorbidities.

  • Renal impairment (CrCl <30 mL/min): halve dose or double interval.
  • Severe hepatic disease: avoid if possible; monitor LFTs.
  • Elderly: assess polypharmacy and interactions before supply.

Q&A — “What If I Miss A Dose?”

Take the missed dose as soon as you remember unless it is almost time for the next dose.

Do not double up doses to make up for a missed one.

If vomiting occurs within 1–2 hours of taking a dose, contact a pharmacist or prescriber about replacement dosing guidance.

Interaction Chart — Drugs, Food And Alcohol (Australian Diet Context)

Food And Drinks

Clarithromycin has no major interaction with coffee, so normal consumption is generally acceptable.

Alcohol does not have a direct chemical interaction but can increase the risk of liver injury and worsen gastrointestinal side effects.

Advise limiting alcohol while taking clarithromycin, particularly in patients with liver disease or on hepatotoxic medicines.

Grapefruit and grapefruit juice are precautionary due to potential CYP3A4 effects with macrolides and should be flagged.

Counsel patients to maintain hydration, especially in hot Australian climates.

Common Drug Conflicts (Priority Australian Prescribing Interactions)

Drug/Class Interaction Risk Recommended Action
Colchicine Serious toxicity if hepatic/renal impairment Avoid co‑administration in impaired patients
Simvastatin, Lovastatin Risk of rhabdomyolysis via CYP3A4 inhibition Stop statin or switch to safer alternative during therapy
Warfarin INR increase possible Monitor INR closely during and after therapy
Certain antiarrhythmics (eg, quinidine) QT prolongation risk Avoid combination or monitor cardiac status
Ergot alkaloids Contraindicated Avoid concomitant use
Ciclosporin Increased ciclosporin levels Monitor levels; adjust dose as needed

Pharmacist screening checklist: include prescription medicines, OTCs, herbal remedies (for example St John’s wort), and recreational drugs when assessing interactions.

User Reports And Consumer Trends In Australia

Patients commonly report clarithromycin is effective for respiratory infections when prescribed appropriately.

Frequent complaints are gastrointestinal side effects such as nausea and diarrhoea, and a metallic or sour taste.

Some users report transient hearing changes at high doses, though this is less common.

Cost and PBS access are recurring concerns among urban and rural patients.

Rural patients note longer wait times for GP scripts and greater reliance on regional pharmacies and telehealth services.

Urban patients often compare pricing across major chains or opt for online repeat prescriptions.

  • Top 5 Patient Concerns: side effects, cost, dosing convenience, paediatric suspension availability, interactions.
  • Sentiment summary: positive on efficacy; negative on GI effects, taste and cost.

Access And Purchase Options In Australia

National Pharmacy Chains And Community Options

Major pharmacy chains include Chemist Warehouse, Priceline and TerryWhite Chemmart.

Independent community pharmacies and Aboriginal Community Controlled Health Services are important in remote areas.

Specific brand and formulation availability varies by outlet and by current stock.

Comparison table suggestion for authors: pharmacy versus typical stock, price range and delivery options.

Online Pharmacies, Telehealth And E‑Prescriptions

Australian telehealth services commonly provide e‑prescriptions that community pharmacies can dispense from.

Verify the dispensing pharmacy is registered and confirm ARTG listings for any unfamiliar brand.

Avoid cross‑border sourcing of unregistered generics without prescriber approval due to registration and quality concerns.

Legal procurement checklist: GP consult → e‑script → dispense at registered Australian pharmacy → check PBS eligibility.

In our online pharmacy, biaxin is available without a prescription, with discreet delivery to Australia in 9‑21 days.

Mechanism Of Action And Pharmacology

Simplified Mechanism

Clarithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.

The effect may be bacteriostatic or bactericidal depending on the organism and drug concentration.

It has an active metabolite, 14‑hydroxy‑clarithromycin, which contributes to activity particularly against Haemophilus species.

Clarithromycin achieves good penetration into respiratory tissues, which supports its use in chest infections.

Clinical Pharmacology Terms

  • Half‑Life: time for plasma concentration to halve; guides dosing interval.
  • Bioavailability: proportion absorbed and available systemically after oral dosing.
  • Active Metabolite: 14‑hydroxy‑clarithromycin contributes to antibacterial effect.
  • CYP3A4 Metabolism: clarithromycin inhibits CYP3A4 leading to many interactions.
  • MIC: minimum inhibitory concentration, key to predicting efficacy.
  • Distribution: tissue penetration, notably in the respiratory tract.

Refer to the TGA Product Information for full pharmacokinetic details when counselling complex patients.

Indications And Common Off‑Label Uses In Australian Practice

TGA‑Recognised And Common Indications

Indication Standard Adult Dose Typical Duration
Community‑acquired pneumonia 250–500 mg every 12 hours 7–14 days
Acute maxillary sinusitis 500 mg every 12 hours 14 days
H. pylori (with amoxicillin + PPI) 500 mg every 12 hours 7–14 days
MAC (HIV) 500 mg every 12 hours + ethambutol ± others Specialist regimen

Off‑Label Uses And Cautions

Off‑label uses include certain bronchiectasis exacerbations and selected ENT chronic regimens under specialist advice.

Do not use for viral infections and avoid routine use where first‑line agents are effective to reduce resistance risk.

  • Refer to infectious‑disease specialists for complex mycobacterial or long‑term suppressive therapy.
  • Consider antimicrobial stewardship policies when selecting clarithromycin over alternatives.

Key Clinical Findings And Evidence Summary (2022–2026 Focus)

When updating trials, search PubMed, Cochrane, MJA and TGA safety communications for studies from 2022 onward.

Key topics to capture include clarithromycin versus azithromycin or β‑lactams for community‑acquired pneumonia, and H. pylori eradication rates amid rising macrolide resistance.

Review meta‑analyses on QT prolongation and cardiac risk linked to macrolides and studies describing CYP3A4 interaction outcomes.

For each study summarise design, population (note any Australian cohorts), outcomes such as clinical cure, adverse events and resistance rates, and implications for PBS prescribing.

Suggested trial summary table fields: author, year, design, n, primary outcome, relevance to Australian practice and evidence level.

Alternatives Matrix (PBS‑Listed Alternatives And Pros/Cons)

Comparative Options

Drug ATC Typical Dosing Main Pros Main Cons
Azithromycin J01FA10 Often once daily short courses Convenient dosing Resistance concerns; different interaction profile
Erythromycin J01FA01 Multiple daily dosing Older macrolide option GI irritation; dosing frequency
Roxithromycin J01FA06 Twice daily dosing Alternative macrolide Availability varies
Amoxicillin‑Clavulanate J01CR02 Typically twice daily or thrice Good beta‑lactam coverage for many respiratory pathogens Not suitable in penicillin allergy
Levofloxacin J01MA12 Once daily dosing Broad coverage including atypicals Fluoroquinolone safety concerns

Choosing An Alternative In Practice

  • Allergy first — rule out macrolide or penicillin allergy.
  • Consider infection site and likely pathogens along with local resistance patterns.
  • Review comorbidities such as cardiac, renal and hepatic disease that affect choice.
  • Check interactions and PBS availability to align with patient cost preferences.

Common Questions From Australian Pharmacy Consultations (FAQ Bank)

Can I breastfeed while taking clarithromycin?

Discuss with the prescriber; monitor the infant for gastrointestinal effects if treatment is necessary.

Is it safe in pregnancy?

Only use if clearly needed and after a risk–benefit discussion with the prescriber.

Will it interfere with my statin?

Avoid simvastatin and lovastatin during clarithromycin therapy or stop/replace the statin temporarily as advised.

How long before symptoms improve?

Many patients notice improvement within 48–72 hours but complete the full course unless advised otherwise.

What to do with severe diarrhoea?

Seek immediate medical review due to the risk of C. difficile infection and dehydration.

Provide a one‑page printable leaflet for patients covering side effects, storage and when to seek urgent care.

Price And Access Comparison Table (Practical Draft For Article)

Table Structure And Sample Fields

Pharmacy/Source Brand Vs Generic Typical Price Range (Cash) PBS Subsidy Status Prescription Required Home Delivery Available Notes On Stock Reliability
Chemist Warehouse Varies (branded & generic) Varies Check PBS Y Y Large national chain; variable stock by store
Priceline Varies Varies Check PBS Y Y Urban availability typically good
TerryWhite Chemmart Varies Varies Check PBS Y Y Community network; good local access
Local Independent Pharmacy Often generic Varies Check PBS Y May vary Stock can be limited in remote areas

Rural Vs Urban Access Considerations

Expect possible supply delays in remote regions and rely on community health services and outreach pharmacists.

Contingency steps include requesting repeat prescriptions earlier and liaising with local clinics to ensure continuity.

Registration, Regulation And Quality Assurance (TGA/PBS Practicalities)

TGA Registration And ARTG Checks

Quote ARTG numbers for particular brands where possible and link to the TGA Product Information for safety updates.

Confirm ARTG entry for each marketed product before recommending or sourcing an overseas product.

Check TGA safety communications periodically for updates on QT or hepatic warnings related to macrolides.

PBS Subsidy And Prescribing Rules

PBS listings can be indication‑specific and require authority prescriptions for some uses.

Clinicians and pharmacists should check the PBS Schedule for current restrictions and submission rules.

Quality assurance: always reference the original Product Information from the manufacturer and peer‑reviewed literature when advising on off‑label use.

Storage, Transport And Handling (Home & Pharmacy)

Household Storage (Australian Climate)

Tablets should be stored below 25°C and protected from light and moisture.

Reconstituted oral suspension must be refrigerated at 2–8°C and discarded after 14 days.

Advise patients to keep medicines away from children and pets and to avoid storage in very humid or hot locations.

  • Keep in original packaging with clear expiry noted after reconstitution.
  • Do not freeze the suspension.
  • Return unused medicines to a pharmacy for safe disposal.

Pharmacy Cold‑Chain And Dispensing Notes

Pharmacies should label reconstituted suspension with the date of reconstitution and an expiry of 14 days.

Document storage temperatures and actions to take after any temperature excursions following local protocols.

Item Storage Temperature Action If Breached
Tablets Below 25°C Review integrity; advise patient if compromised
Reconstituted Suspension 2–8°C; discard after 14 days Discard if out of range; reissue prescription if required

Guidelines For Proper Use — Pharmacist Counselling Script & Patient Advice

Pharmacist Counselling Style And Checklist

Confirm the indication and the prescribed dose and duration with the patient.

Explain how to take the medicine and mention any formulation‑specific advice such as with or without food for IR versus XR tablets.

Emphasise adherence and completing the full course even if symptoms improve.

Describe common side effects including nausea, diarrhoea and taste disturbance and when to seek help.

Review prescription and OTC medicines for interactions and document any allergies.

Scripted prompt for dispensing: “This medicine is clarithromycin; take X mg twice daily for Y days. Expect possible nausea or a metallic taste. Stop and seek urgent help for severe diarrhoea, jaundice or palpitations.”

Patient Handout Items And National Guidance

Include PBS/TGA patient information leaflets and links to local antibiotic stewardship resources such as state health pages and RACGP guidance.

Provide a one‑page disposal and storage reminder and a short definition list for any clinical terms used.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9‑14 days
Melbourne Victoria 9‑14 days
Brisbane Queensland 9‑14 days
Perth Western Australia 9‑14 days
Adelaide South Australia 9‑14 days
Canberra Australian Capital Territory 9‑14 days
Hobart Tasmania 9‑14 days
Darwin Northern Territory 9‑14 days
Gold Coast Queensland 14‑21 days
Newcastle New South Wales 14‑21 days
Wollongong New South Wales 14‑21 days
Cairns Queensland 14‑21 days
Townsville Queensland 14‑21 days

Related products